Volume 6, Issue 4, December 2018, Page: 169-174
Effect of Supra-Physiological Doses of Anabolic-Androgenic Steroids on the Neuronal Density of the Central and Basolateral Amygdala in Mice
Débora Mantoan Alves, Institute of Biomedical Sciences, Department of Anatomy, Federal University of Alfenas, Alfenas, Brazil
Wagner Costa Rossi Junior, Institute of Biomedical Sciences, Department of Anatomy, Federal University of Alfenas, Alfenas, Brazil
Flávia Da Ré Guerra, Institute of Biomedical Sciences, Department of Anatomy, Federal University of Alfenas, Alfenas, Brazil
Evelise Aline Soares, Medical School, Federal University of Alfenas, Alfenas, Brazil
Petrus Pires Marques, Department of Morphology, Medical School, José Vellano University, Unifenas, Alfenas, Brazil
Alessandra Esteves, Institute of Biomedical Sciences, Department of Anatomy, Federal University of Alfenas, Alfenas, Brazil
Received: Sep. 30, 2018;       Accepted: Oct. 18, 2018;       Published: Nov. 15, 2018
DOI: 10.11648/j.ajss.20180604.16      View  84      Downloads  17
Abstract
Anabolic-androgenic steroids (AAS), despite being controlled by government agencies, are illegally marketed and heavily consumed among youngsters that want a lean, muscular appearance and improved physical performance. Behavioral changes mediated by the amygdala, such as depression, aggressiveness and anxiety, are reported among users. The main scope of this work is to quantify the number of neuron cells on the nuclei of the central (CA) and basolateral (BLA) mice's amygdala submitted to a chronic supra-physiological doses of Durateston® (a combination of testosterone propionate, testosterone isocaproate and testosterone decanoate) and Deca Durabolin® (nandrolone decanoate), administered isolated and combined. For this purpose, 40 Swiss male mice were taken and divided into 4 (four) groups (n = 10): a control group (C), in which mice received saline solution; a Dura group, in which mice received Durateston®; a Deca group, in which mice received Deca Durabolin®; and a Dura-Deca group, in which mice received both drugs. Mice were treated with AAS for a period of 60 days and underwent exercises (swimming). After this time, mice were euthanized and had their brains removed. The material thus obtained was processed in a conventional histological routine. For the neuron cells quantitative analyses, the simple random sampling count method was used. The results showed that there was a significant decrease in the number of neuron cells in all AAS treated animals comparing to the control group; concerning the amygdala basolateral nucleus, the decrease ranged from 23% to 36%, according to the AAS selected group; regarding the amygdala central nucleus, the decrease ranged from 20% to 29%, according to the AAS selected group. One can conclude that the administration of supra-physiological doses of these AAS causes decrease in the number of neuron cells on the central and basolateral nuclei of Swiss male mice's amygdala.
Keywords
Anabolic-Androgenic Steroids, Central Amygdala, Basolateral Amygdala, Neuron Density
To cite this article
Débora Mantoan Alves, Wagner Costa Rossi Junior, Flávia Da Ré Guerra, Evelise Aline Soares, Petrus Pires Marques, Alessandra Esteves, Effect of Supra-Physiological Doses of Anabolic-Androgenic Steroids on the Neuronal Density of the Central and Basolateral Amygdala in Mice, American Journal of Sports Science. Vol. 6, No. 4, 2018, pp. 169-174. doi: 10.11648/j.ajss.20180604.16
Copyright
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
A. D. J. E Mooradian. Biological actions of androgens. Endocrine Reviews, 8 (1987): 1-28.
[2]
N. T Shahidi. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clinical Therapeutics, 23 (2001): 1355-1390.
[3]
R. D Kersey, D. L Elliot, L Goldberg, G Kanayama, J. E Leone, M Pavlovich , H. G Jr Pope. National athletic trainers' association position statement: Anabolic-androgenic steroids. Journal of Athletic Training, 47 (2012): 567-588. http://dx.doi.org/10.4085/1062-6050-47.5.08.
[4]
M. F Rocha, F Aguiar, H Ramos. O uso de esteroides androgênicos anabolizantes e outros suplementos ergogénicos – uma epidemia silenciosa. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 9 (2014): 98-105. http://dx.doi.org/10.1016/j.rpedm.2014.09.002.
[5]
J. L Dotson, R. T Brown. The history of the development of anabolic-androgenic steroids. Pediatric Clinics of North America, 54 (2007): 761-769. http://dx.doi.org/10.1016/j.pcl.2007.04.003.
[6]
F. P Busardo, P Frati, M. D Sanzo, S Napoletano , E Pinchi , S Zaami , V Fineschi. The impact of nandrolone decanoate on the central nervous system. Current Neuropharmacology, 13(2015): 122-131. http://dx.doi.org/10.2174/1570159X13666141210225822.
[7]
P Tucci, M. G Morgese, M Colaianna, M Zotti, S Schiavone, V Cuomo, L Trabace. Neurochemical consequence of steroid abuse: stanozolol-induced monoaminergic changes. Steroids, 77 (2012): 269-275. http://dx.doi.org/10.1016/j.steroids.2011.12.014
[8]
C Pomara, M Neri, S Bello, F Carmela, R Irene, E Turillazzi. Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review. Current Neuropharmacology, 13(2015): 132-145. http://dx.doi.org/10.2174/1570159X13666141210221434.
[9]
G Kanayama, K. J Brower, R. I Wood, J. I Hudson, H. G Pope Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction, 104 (2009): 1966-1978. http://dx.doi.org/10.1111/j.1360-0443.2009.02734.x.
[10]
H. G Pope, R. I Wood, A Rogol, F Nyberg, L Bowers, S Bhasin. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocrine Reviews, 35 (2014): 341-375. http://dx.doi.org/10.1210/er.2013-1058.
[11]
S. D Vann. Dismantling the Papez circuit for memory in rats. eLife, 25(2013): e00736. http://dx.doi.org/ 10.7554/eLife.00736.
[12]
S Duvarci, D Pare. Amygdala microcircuits controlling learned fear. Neuron, 82 (2014): 966-980. http://dx.doi.org/10.1016/j.neuron.2014.04.042.
[13]
AJ McDonald. Cortical pathways to the mammalian amygdala. Progress in Neurobiology, 55(1998): 257-332.
[14]
R. I Wood. Anabolic-androgenic steroid dependence? Insights from animals and humans. Frontiers in Neuroendocrinology, 29 (2008): 490-506. https://doi.org/doi: 10.1016/j.yfrne.2007.12.0.
[15]
L. S. I Doddamani, Y Jayamma. Acceleration of neutrophil precursors' maturation and immunostimulation of CD3+, CD4+ lymphocytes by stanozolol in mice. The Journal of Steroid Biochemistry and Molecular Biology, 129 (2012): 172-178. https://doi.org/doi: 10.1016/j.jsbmb.2011.11.008.
[16]
C. M Ribeiro, D. K Silva, B Damião, D. M Alves, A. C Freitas, WC Rossi Junior, A Esteves. Análise quantitativa de células de Purkinje em camundongos sob o uso dos esteroides anabolizantes. Revista Neurociências, 22 (2014): 432-437. doi:10.4181/RNC.2014.22.03.969.6p.
[17]
D. K Silva, A Esteves, W. C Rossi Junior, D. A Nogueira. Quantidade de células de Purkinje no cerebelo de camundongos sob o uso de esteroides anabolizantes. Revista Neurociências, 20 (2012):200-203. doi: 10.4181/RNC.2012.20.690.4p.
[18]
C. S von Bartheld, J Bahney, S Herculano-Houzel. The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting. Journal of Comparative Neurology, 524 (2016): 3865-3895. doi: 10.1002/cne.24040.
[19]
K. B. J. Franklin, G. Paxinos. Paxinos and Franklin's The mouse brain in stereotaxic coordinates, 3rd edn, Academic Press, an imprint of Elsevier, New York.
[20]
A Kádár, E Sánchez, G Wittmann, P. S Singru, T Füzesi, A Marsili, P. R Larsen, Z Liposits, R. M Lechan, C Fekete. Distribution of Hypophysiotropic Thyrotropin-Releasing Hormone (TRH)-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus of the Mouse. The Journal of Comparative Neurology, 518 (2010): 3948-3961. doi: 10.1002/cne.22432.
[21]
M. A Garcia-Cabezas, Y. J John, H Barbas, B Zikopoulos. Distinction of Neurons, Glia and Endothelial Cells in the Cerebral Cortex: An Algorithm Based on Cytological Features. Frontiers in Neuroanatomy, 10 (2016) 107. doi: 10.3389/fnana.2016.00107.
[22]
C. A Mandarim-de-Lacerda. Stereological tools in biomedical research, Anais da Academia Brasileira de Ciências, 75 (2003): 469-486.
[23]
R. W Boyce, K. A Dorph-Petersen, L Lyck, H. J Gundersen. Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicologic Pathology, 38 (2010): 1011-1025. doi: 10.1177/0192623310385140.
[24]
C Muhlfeld, T Papadakis, G Krasteva, J. R Nyengaard, U Hahn, W Kummer. An unbiased stereological method for efficiently quantifying the innervation of the heart and other organs based on total length estimations. Journal of Applied Physiology, 108 (2010): 1402-1409. doi:10.1152/japplphysiol.01013.2009.
[25]
F Caraci, V Pistara, A Corsaro, F Tomasello, M. L Giuffrida, MA Sortino, F Nicoletti, A Copani. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. Journal of Neuroscience Research, 89 (2011): 592-600. doi:10.1002/jnr.22578.
[26]
Carmo CA, Goncalves AL, Salvadori DM, E. L Maistro. Nandrolone androgenic hormone presents genotoxic effects in different cells of mice. Journal of Applied Toxicology, 32 (2012): 810-814. doi:10.1002/jat.1701.
[27]
S Scaccianoce, A Caruso, J Miele, R Nistico', F Nicoletti. Potential neurodegenerative effect of anabolic androgenic steroid abuse. Journal of Biological Regulators & Homeostatic Agents, 27 (2013): 107-114.
[28]
J. C Wommack, Y Delville. Chronic social stress during puberty enhances tyrosine hydroxylase immunoreactivity within the limbic system in golden hamsters. Brain Research, 933 (2002): 139-143.
[29]
Z Pirnik, A Kiss. Fos expression variances in mouse hypothalamus upon physical and osmotic stimuli: co-staining with vasopressin, oxytocin, and tyrosine hydroxylase. Brain Research Bulletin, 65 (2005): 423-431. doi:10.1016/j.brainresbull.2005.02.023.
[30]
J. J Schwartzer, R. H Melloni Jr. Dopamine activity in the lateral anterior hypothalamus modulates AAS-induced aggression through D2 but not D5 receptors. Behavioral Neuroscience, 124 (2010): 645-655. doi: 10.1037/a0020899.
[31]
K. M Wassum, A Izquierdo. The basolateral amygdala in reward learning and addiction, Neuroscience & Biobehavioral Reviews, 57 (2015): 271-283. doi: 10.1016/j.neubiorev.2015.08.017.
[32]
L. A Ricci, T. R Morrison, R. H Melloni Jr. Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters. Hormones and Behavior, 62 (2012): 569-578. doi:10.1016/j.yhbeh.2012.09.007.
[33]
G Ambar, S Chiavegatto. Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice. Genes, Brain and Behavior, 8 (2009): 161-173. doi:10.1111/j.1601-183X.2008.00458.x.
[34]
A. J McDonald, V Zaric. Extrinsic origins of the somatostatin and neuropeptide Y innervation of the rat basolateral amygdala. Neuroscience, 294 (2015): 82-100. doi:10.1016/j.neuroscience.2015.03.004.
[35]
Y Silberman, D. G Winder. Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala. Neuropharmacology, vol 70 (2013): 316-323. https://doi.org/doi:10.1016/j.neuropharm.2013.02.014.
[36]
Y Silberman, T. L Fetterly, E. K Awad, E. J Milano, T. B Usdin, D. G Winder. Ethanol produces corticotropin-releasing factor receptor-dependent enhancement of spontaneous glutamatergic transmission in the mouse central amygdala. Alcoholism: Clinical and Experimental Research, 39 (2015): 2154-2162. doi:10.1111/acer.12881
[37]
R Benini, M Avoli. Altered inhibition in lateral amygdala networks in a rat model of temporal lobe epilepsy. Journal of Neurophysiology, 95 (2006): 2143-2154. doi:10.1152/jn.01217.2005.
[38]
J. A Rosenkranz, E. R Venheim, M Padival. Chronic stress causes amygdala hyperexcitability in rodents. Biological Psychiatry, 67 (2010): 1128-1136. doi:10.1016/j.biopsych.2010.02.008
[39]
L Tran, B. K Lasher, K. A Young, N. B Keele. Depletion of serotonin in the basolateral amygdala elevates glutamate receptors and facilitates fear-potentiated startle. Translational Psychiatry, 3 (2013): 2-8. doi:10.1038/tp.2013.66.
[40]
S. G Fischer, L. A Ricci, R. H Melloni Jr. Repeated anabolic/androgenic steroid exposure during adolescence alters phosphate-activated glutaminase and glutamate receptor 1 (GluR1) subunit immunoreactivity in Hamster brain: correlation with offensive aggression. Behavioural Brain Research, 180 (2007): 77-85. doi:10.1016/j.bbr.2007.02.025.
[41]
F Ventriglia, V Di Maio. Effects of AMPARs trafficking and glutamate-receptors binding probability on stochastic variability of EPSC. Biosystems, 112(2013): 298-304. doi:10.1016/j.biosystems.2013.01.010.
[42]
A. N Siddiqui, N Siddiqui, R. A Khan, N. R Jabir, M. A Kamal, C. K Firoz, S Tabrez. Neuroprotective Role of Steroidal Sex Hormones: An Overview. CNS Neuroscience & Therapeutics, 22 (2016): 342-350. doi:10.1111/cns.12538.
[43]
R Sattler, M Tymianski. Molecular mechanisms of calcium-dependent excitotoxicity. Journal of Molecular Medicine, 78 (2000): 3-13.
[44]
I. M Araujo, B. P Carreira, C. M Carvalho, A. P Carvalho. Calpains and delayed calcium deregulation in excitotoxicity. Neurochemical Research, 35 (2010): 1966-1969.
[45]
Y Wang, J. W Zyskind, D. J Colacurcio, A. L Kathryn, H. T Jenhao, G Galina, L Kelly. Jordan-Sciutto. Differential roles for caspase-mediated and calpain-mediated cell death in 1- and 3-week-old rat cortical cultures. NeuroReport, 23 (2012): 1052-1058. doi:10.1097/WNR.0b013e32835ad25d.
[46]
K. L Mcintyre, D. M Porter, L. P Henderson. Anabolic androgenic steroids induce age, sex, and dose-dependent changes in GABA(A) receptor subunit mRNAs in the mouse forebrain. Neuropharmacology, 43(2002): 634-645.
[47]
R. P Venkitakrishnan, O Benard, M Max, J. L Markley, F. M Assadi-Porter. Use of NMR saturation transfer difference spectroscopy to study ligand binding to membrane proteins, Methods in Molecular Biology, 914 (2012): 47-63. doi:10.1007/978-1-62703-023-6_4.
[48]
A. H Lin, R. W Li, E. Y Ho, P. H. L George, W. S. L Susan, M. V Paul, Y. K. M Ricky. Differential ligand binding affinities of human estrogen receptor-alpha isoforms. PLoS One, 8 (2013): 1-9. https://doi.org/doi:10.1371/journal.pone.0063199.
[49]
R Orlando, A Caruso, G Molinaro, M Motolese, F Matrisciano, G Togna, D Melchiorri, F Nicoletti , V Bruno. Nanomolar concentrations of anabolic–androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures. Brain Research, 1165 (2007): 21-29. doi:10.1016/j.brainres.2007.06.047.
[50]
B. Damião, G. G Souza, D. A Nogueria, W. C Rossi Junior, G. J. M Fernandes, A Esteves. Quantificação de corpos de neurônios em camundongos submetidos ao uso de esteroides anabolizantes. Revista Neurociências, 20(2012): 68-72.
[51]
D. K. Silva, A. Esteves, F. D. R. Guerra, E. A. Soares, D. A. Nogueria, P. P. Marques, W. C. Rossi Junior. Chronic Use of Anabolic Steroids and the Effects on the Neuronal Density of the Cerebral Cortex and Hippocampus in Mice. American Journal of Sports Science. 6(2018): 122-129. doi: 10.11648/j.ajss.20180603.18.
[52]
A. C. Freitas, B. Damião, D. M Alves, M. Ribeiro, G. J. M Fernandes, W. C. Rossi Junior, A. Esteves. Efeitos dos anabolizantes sobre a densidade de neurônios dos núcleos da base. Rev Bras Med Esporte. 23 (2017): 213-216. doi: doi:10.1590/1517-869220172303151688.
Browse journals by subject